首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Documenting Penicillin Allergy: The Impact of Inconsistency
Authors:Nirav S Shah  Jessica P Ridgway  Natasha Pettit  John Fahrenbach  Ari Robicsek
Institution:1. Department of Medicine, University of Chicago, Chicago, Illinois, United States of America;2. Department of Clinical Analytics, Northshore University HealthSystem, Evanston, Illinois, United States of America;3. Department of Medicine, Northshore University HealthSystem, Evanston, Illinois, United States of America;Chang-Gung University, TAIWAN
Abstract:

Background

Allergy documentation is frequently inconsistent and incomplete. The impact of this variability on subsequent treatment is not well described.

Objective

To determine how allergy documentation affects subsequent antibiotic choice.

Design

Retrospective, cohort study.

Participants

232,616 adult patients seen by 199 primary care providers (PCPs) between January 1, 2009 and January 1, 2014 at an academic medical system.

Main Measures

Inter-physician variation in beta-lactam allergy documentation; antibiotic treatment following beta-lactam allergy documentation.

Key Results

15.6% of patients had a reported beta-lactam allergy. Of those patients, 39.8% had a specific allergen identified and 22.7% had allergic reaction characteristics documented. Variation between PCPs was greater than would be expected by chance (all p<0.001) in the percentage of their patients with a documented beta-lactam allergy (7.9% to 24.8%), identification of a specific allergen (e.g. amoxicillin as opposed to “penicillins”) (24.0% to 58.2%) and documentation of the reaction characteristics (5.4% to 51.9%). After beta-lactam allergy documentation, patients were less likely to receive penicillins (Relative Risk RR] 0.16 95% Confidence Interval: 0.15–0.17]) and cephalosporins (RR 0.28 95% CI 0.27–0.30]) and more likely to receive fluoroquinolones (RR 1.5 95% CI 1.5–1.6]), clindamycin (RR 3.8 95% CI 3.6–4.0]) and vancomycin (RR 5.0 95% CI 4.3–5.8]). Among patients with beta-lactam allergy, rechallenge was more likely when a specific allergen was identified (RR 1.6 95% CI 1.5–1.8]) and when reaction characteristics were documented (RR 2.0 95% CI 1.8–2.2]).

Conclusions

Provider documentation of beta-lactam allergy is highly variable, and details of the allergy are infrequently documented. Classification of a patient as beta-lactam allergic and incomplete documentation regarding the details of the allergy lead to beta-lactam avoidance and use of other antimicrobial agents, behaviors that may adversely impact care quality and cost.
Keywords:
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号